Epigenetic Marks May Alter Diet Benefits in Type 2 Diabetes

Diet Protection May Depend on DNA Methylation Patterns

A healthy diet does not reduce the risk of type 2 diabetes equally across all biological profiles. Researchers at the German Center for Diabetes Research (DZD) and the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE) published these findings in Cardiovascular Diabetology. Their analysis examined how an individual's underlying genetic risk and epigenetic marks influence the protective effect of food choices.

The team evaluated long-term data from the European Prospective Investigation into Cancer and Nutrition (EPIC) Potsdam cohort. That parent study has tracked more than 27,000 participants since the 1990s. The researchers evaluated whether biological susceptibility changes the real-world impact of a balanced diet.

Genetic Risk Did Not Change Dietary Benefits

Inherited genetic predisposition to type 2 diabetes does not diminish the protective association of a balanced diet. To assess inherited susceptibility, the investigators analyzed genetic data from 2,204 randomly selected subcohort participants and 750 participants with newly diagnosed type 2 diabetes. They scored each participant using polygenic risk scores (PRS).

The mathematical model revealed no interaction between a participant's genetic score and their diet quality. People with high polygenic risk scores experienced lower rates of diabetes when eating balanced diets, matching the benefits seen in people with lower genetic risk scores. The protective association of food choice remained stable regardless of baseline inherited risk.

Epigenetic Risk Scores Altered Observed Dietary Protection

Epigenetic changes in DNA were linked to differences in how strongly diet associated with diabetes incidence. Epigenetics refers to chemical modifications such as deoxyribonucleic acid (DNA) methylation that alter gene activity without changing the underlying genetic sequence. The researchers assessed DNA methylation patterns across 1,065 subcohort participants and 676 diabetes cases.

The study authors compiled established diabetes-related DNA methylation sites into an aggregate methylation risk score (MRS). Higher methylation scores tracked with a higher risk of developing type 2 diabetes later in life. Furthermore, participants with higher methylation scores did not display the expected reduction in diabetes incidence from a healthy diet.

Participants with a lower methylation risk score showed clear protection from higher-quality diets. Those diets emphasized vegetables, fruit, whole grains, legumes, nuts, fish, and plant-based fats, while limiting red meat, processed meat, and sugar-sweetened beverages.

Study Design Limits and Clinical Considerations

These observational cohort findings cannot establish direct biological causation between DNA methylation and dietary resistance. Diet quality was calculated through established nutritional indices that assess inflammatory and health-promoting characteristics, but self-reported intake methods carry measurement errors. The analysis also focused exclusively on participants from the Potsdam region.

Lead author Christine El-Khoury and senior author Matthias Schulze noted that clinical prevention protocols cannot yet change based on these observations. The associations require validation in independent cohorts with diverse populations before clinicians can use epigenetic scores to guide nutrition therapy. For now, general guidelines emphasizing whole plant foods, unsaturated fats, and low sugar intake remain the standard recommendation for metabolic health.